HRT FINANCIAL LP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 19 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$755
-99.9%
74,9070.0%0.01%
+37.5%
Q3 2022$742,000
+1.5%
74,9070.0%0.01%0.0%
Q2 2022$731,0000.0%74,9070.0%0.01%
+60.0%
Q1 2022$731,000
-1.3%
74,9070.0%0.01%
+25.0%
Q4 2021$741,000
-0.4%
74,9070.0%0.00%
-20.0%
Q3 2021$744,000
-0.4%
74,9070.0%0.01%
-28.6%
Q2 2021$747,000
-7.2%
74,907
-6.5%
0.01%
-12.5%
Q1 2021$805,00080,1310.01%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
First Trust Capital Management L.P. 210,000$2,098,0000.31%
Arena Capital Advisors, LLC- CA 225,899$2,257,0000.19%
PERISCOPE CAPITAL INC. 465,285$4,648,0000.15%
Wealthspring Capital LLC 54,647$545,0000.14%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$657,0000.08%
Mint Tower Capital Management B.V. 100,000$999,0000.07%
Sage Mountain Advisors LLC 41,340$413,0000.07%
GLAZER CAPITAL, LLC 284,104$2,838,0000.04%
KING STREET CAPITAL MANAGEMENT, L.P. 50,000$500,0000.04%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 30,062$300,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders